|
ADPT
|
Adaptive Biotechnologies Corporation
|
US
|
NASDAQ
|
|
ANIX
|
Anixa Biosciences, Inc.
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
US
|
NASDAQ
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|
|
HCWB
|
HCW Biologics Inc.
|
US
|
NASDAQ
|
|
INO
|
Inovio Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
US
|
NASDAQ
|
|
NEO
|
NeoGenomics, Inc.
|
US
|
NASDAQ
|
|
NEXI
|
NexImmune, Inc.
|
US
|
NASDAQ
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PSTX
|
Poseida Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SBFM
|
Sunshine Biopharma Inc.
|
US
|
NASDAQ
|
|
SYRS
|
Syros Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
TEVA
|
Teva Pharmaceutical Industries
|
US
|
NYSE
|
|
VINC
|
Vincera Pharma, Inc.
|
US
|
NASDAQ
|